Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Jan 2009
Meta AnalysisMeta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
To determine the relationship between non-high-density lipoprotein cholesterol (HDL-C) lowering and coronary heart disease (CHD) risk reduction for various lipid-modifying therapies. ⋯ Non-HDL-C is an important target of therapy for CHD prevention. Most lipid-modifying drugs used as monotherapy have an approximately 1:1 relationship between percent non-HDL-C lowering and CHD reduction.